Nanobiotix (NBTX) Invested Capital (2018 - 2025)
Nanobiotix has reported Invested Capital over the past 8 years, most recently at $12.6 million for Q4 2025.
- For Q4 2025, Invested Capital rose 179.76% year-over-year to $12.6 million; the TTM value through Dec 2025 reached $12.6 million, up 179.76%, while the annual FY2025 figure was $12.6 million, 179.76% up from the prior year.
- Invested Capital for Q4 2025 was $12.6 million at Nanobiotix, up from -$72.7 million in the prior quarter.
- Over five years, Invested Capital peaked at $83.3 million in Q4 2021 and troughed at -$72.7 million in Q2 2025.
- A 5-year average of $9.0 million and a median of $12.1 million in 2022 define the central range for Invested Capital.
- Biggest five-year swings in Invested Capital: tumbled 510.32% in 2023 and later soared 179.76% in 2025.
- Year by year, Invested Capital stood at $83.3 million in 2021, then plummeted by 68.0% to $26.7 million in 2022, then skyrocketed by 96.68% to $52.4 million in 2023, then tumbled by 130.17% to -$15.8 million in 2024, then soared by 179.76% to $12.6 million in 2025.
- Business Quant data shows Invested Capital for NBTX at $12.6 million in Q4 2025, -$72.7 million in Q2 2025, and -$15.8 million in Q4 2024.